Imprida е изследван и в активно- контролирано проучване при 130 пациенти с хипертония с диастолно налягане ≥110 mmHg и < 120 mmHg.
Imprida was also studied in an active-controlled study of 130 hypertensive patients with diastolic blood pressure ≥ 110 mmHg and < 120 mmHg.